| [1] |
. Nat Rev Immunol，2019，19（3）： 154-169.
|
| [2] |
Murakami T，Ockinger J，Yu J，et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome［J］. PNAS，2012，109（28）： 11282-11287.
|
| [3] |
He Y，Zeng MY，Yang D，et al. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux［J］. Nature，2016，530（7590）： 354-357.
|
| [4] |
Kuri P，Schieber NL，Thumberger T，et al. Dynamics of in vivo ASC speck formation［J］. J Cell Biol，2017，216（9）： 2891-2909.
|
| [5] |
Dick MS，Sborgi L，Rühl S，et al. ASC filament formation serves as a signal amplification mechanism for inflammasomes［J］. Nat Commun，2016，7： 11929.
|
| [6] |
Hoss F，Rodriguez-Alcazar JF，Latz E. Assembly and regulation of ASC specks［J］. Cell Mol Life Sci，2017，74（7）： 1211-1229.
|
| [7] |
Broz P，Dixit VM. Inflammasomes： mechanism of assembly，regulation and signalling［J］. Nat Rev Immunol，2016，16（7）： 407-420.
|
| [8] |
Barnett KC，Ting JP. Mitochondrial GSDMD pores DAMPen pyroptosis［J］. Immunity，2020，52（3）： 424-426.
|
| [9] |
Swanson KV，Deng M，Ting JP. The NLRP3 inflammasome： molecular activation and regulation to therapeutics［J］. Nat Rev Immunol，2019，19（8）： 477-489.
|
| [10] |
Wu JS，Sun JY，Meng XL. Pyroptosis by caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases［J］. Pharmacol Res，2021，165： 105408.
|
| [11] |
Bauernfeind F，Bartok E，Rieger A，et al. Cutting edge： reactive oxygen species inhibitors block priming，but not activation，of the NLRP3 inflammasome［J］. J Immunol，2011，187（2）： 613-617.
|
| [12] |
Mu?oz-Planillo R，Kuffa P，Martínez-Colón G，et al. K? efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter［J］. Immunity，2013，38（6）： 1142-1153.
|
| [13] |
Zhang YF，Rong H，Zhang FX，et al. A membrane potential- and calpain-dependent reversal of caspase-1 inhibition regulates canonical NLRP3 inflammasome［J］. Cell Rep，2018，24（9）： 2356-2369.
|
| [14] |
Gro? CJ，Mishra R，Schneider KS，et al. K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria［J］. Immunity，2016，45（4）： 761-773.
|
| [15] |
Orlowski GM，Sharma S，Colbert JD，et al. Frontline Science： multiple cathepsins promote inflammasome-independent，particle-induced cell death during NLRP3-dependent IL-1β activation［J］. J Leukoc Biol，2017，102（1）： 7-17.
|
| [16] |
Chen JQ，Chen ZJ. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation［J］. Nature，2018，564（7734）： 71-76.
|
| [17] |
Calvo-Rodriguez M，Kharitonova EK，Bacskai BJ. Therapeutic strategies to target calcium dysregulation in Alzheimer''s disease［J］. Cells，2020，9（11）： E2513.
|
| [18] |
Park YJ，Yoo SA，Kim M，et al. The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases［J］. Front Immunol，2020，11： 195.
|
| [19] |
Michelucci A，García-Casta?eda M，Boncompagni S，et al. Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease［J］. Cell Calcium，2018，76： 101-115.
|
| [20] |
Chu J，Thomas LM，Watkins SC，et al. Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner［J］. J Leukoc Biol，2009，86（5）： 1227-1238.
|
| [21] |
Xi YH，Li HZ，Zhang WH，et al. The functional expression of calcium-sensing receptor in the differentiated THP-1 cells［J］. Mol Cell Biochem，2010，342（1/2）： 233-240.
|
| [22] |
Lee GS，Subramanian N，Kim AI，et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP［J］. Nature，2012，492（7427）： 123-127.
|
| [23] |
Ito M，Yanagi Y，Ichinohe T. Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome［J］. PLoS Pathog，2012，8（8）： e1002857.
|
| [24] |
Shrivastava G，Visoso-Carvajal G，Garcia-Cordero J，et al. Dengue virus serotype 2 and its non-structural proteins 2A and 2B activate NLRP3 inflammasome［J］. Front Immunol，2020，11： 352.
|
| [25] |
Karmakar M，Katsnelson MA，Dubyak GR，et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP［J］. Nat Commun，2016，7： 10555.
|
| [26] |
Ahmad I，Muneer KM，Chang ME，et al. Ultraviolet radiation-induced downregulation of SERCA2 mediates activation of NLRP3 inflammasome in basal cell carcinoma［J］. Photochem Photobiol，2017，93（4）： 1025-1033.
|
| [27] |
Gong T，Wang XQ，Yang YQ，et al. Plant lectins activate the NLRP3 inflammasome to promote inflammatory disorders［J］. J Immunol，2017，198（5）： 2082-2092.
|
| [28] |
Katsnelson MA，Rucker LG，Russo HM，et al. K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling［J］. J Immunol，2015，194（8）： 3937-3952.
|
| [29] |
Katsnelson MA，Lozada-Soto KM，Russo HM，et al. NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption： roles for K+ efflux and Ca2+ influx［J］. Am J Physiol Cell Physiol，2016，311（1）： C83-C100.
|
| [30] |
Zumerle S，Calì B，Munari F，et al. Intercellular calcium signaling induced by ATP potentiates macrophage phagocytosis［J］. Cell Rep，2019，27（1）： 1-10.
|
| [31] |
Zhang CF，Qin JL，Zhang S，et al. ADP/P2Y1 aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation［J］. Mucosal Immunol，2020，13（6）： 931-945.
|
| [32] |
J?ger E，Murthy S，Schmidt C，et al. Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis［J］. Nat Commun，2020，11（1）： 4243.
|
| [33] |
Tauseef M，Knezevic N，Chava KR，et al. TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation［J］. J Exp Med，2012，209（11）： 1953-1968.
|
| [34] |
Zhong ZY，Zhai YG，Liang S，et al. TR/MIN2 links oxidative stress to NLRP3 inflammasome activation［J］. Nat Commun，2013，4（1）： 1-11.
|
| [35] |
Wang MY，Zhang YB，Xu MM，et al. Roles of TRPA1 and TRPV1 in cigarette smoke -induced airway epithelial cell injury model［J］. Free Radic Biol Med，2019，134： 229-238.
|
| [36] |
Compan V，Baroja-Mazo A，López-Castejón G，et al. Cell volume regulation modulates NLRP3 inflammasome activation［J］. Immunity，2012，37（3）： 487-500.
|
| [37] |
Liu CC，Miao Y，Chen RL，et al. STIM1 mediates IAV-induced inflammation of lung epithelial cells by regulating NLRP3 and inflammasome activation via targeting miR-223［J］. Life Sci，2021，266： 118845.
|
| [38] |
Murayama T，Kurebayashi N. Assays for modulators of ryanodine receptor （RyR）/Ca2+ release channel activity for drug discovery for skeletal muscle and heart diseases［J］. Curr Protoc Pharmacol，2019，87（1）： e71.
|
| [39] |
Morgan AJ，Yuan Y，Patel S，et al. Does lysosomal rupture evoke Ca2+ release？ A question of pores and stores［J］. Cell Calcium，2020，86： 102139.
|
| [40] |
Okada M，Matsuzawa A，Yoshimura A，et al. The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation［J］. J Biol Chem，2014，289（47）： 32926-32936.
|
| [41] |
Xu MD，Jiang ZY，Wang CL，et al. Publisher correction： acetate attenuates inflammasome activation through GPR43-mediated Ca2+-dependent NLRP3 ubiquitination［J］. Exp Mol Med，2019，51（8）： 1.
|
| [42] |
Lim JR，Lee HJ，Jung YH，et al. Ethanol-activated CaMKII signaling induces neuronal apoptosis through Drp1-mediated excessive mitochondrial fission and JNK1-dependent NLRP3 inflammasome activation［J］. Cell Commun Signal，2020，18（1）： 123.
|
| [43] |
Chen H，Yang DH，Han FJ，et al. The bacterial T6SS effector EvpP prevents NLRP3 inflammasome activation by inhibiting the Ca2+-dependent MAPK-JNK pathway［J］. Cell Host Microbe，2017，21（1）： 47-58.
|
| [44] |
Nozawa T，Sano S，Minowa-Nozawa A，et al. TBC1D9 regulates TBK1 activation through Ca2+ signaling in selective autophagy［J］. Nat Commun，2020，11（1）： 770.
|
| [45] |
Han XJ，Sun SF，Sun YM，et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy： implications for Parkinson disease［J］. Autophagy，2019，15（11）： 1860-1881.
|
| [46] |
Zhong ZY，Liang S，Sanchez-Lopez E，et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation［J］. Nature，2018，560（7717）： 198-203.
|
| [47] |
Li W，Cao T，Luo CY，et al. Crosstalk between ER stress，NLRP3 inflammasome，and inflammation［J］. Appl Microbiol Biotechnol，2020，104（14）： 6129-6140.
|
| [48] |
Misawa T，Takahama M，Kozaki T，et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome［J］. Nat Immunol，2013，14（5）： 454-460.
|
| [49] |
Li JP，Wei W，Li XX，et al. Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca2+ release in vascular smooth muscle cells in diabetic mice［J］. Life Sci，2020，255： 117758.
|
| [50] |
Rimessi A，Bezzerri V，Patergnani S，et al. Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis［J］. Nat Commun，2015，6： 6201.
|
| [51] |
Rimessi A，Pozzato C，Carparelli L，et al. Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis［J］. Sci Adv，2020，6（19）： eaax9093.
|
| [52] |
Ichinohe T，Yamazaki T，Koshiba T，et al. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection［J］. PNAS，2013，110（44）： 17963-17968.
|
| [53] |
Zhang XW，Wang RH，Hu D，et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer''s disease［J］. Sci Adv，2020，6（49）： eabb8680.
|
| [54] |
Yin NN，Gao QH，Tao WT，et al. Paeoniflorin relieves LPS-induced inflammatory pain in mice by inhibiting NLRP3 inflammasome activation via transient receptor potential vanilloid 1［J］. J Leukoc Biol，2020，108（1）： 229-241.
|
| [55] |
Inzucchi SE，Fitchett D，Juri?i?-Er?en D，et al. Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy［J］？Diabetes Obes Metab，2020，22（4）： 631-639.
|
| [56] |
Zhou ZE，Jardine MJ，Li Q，et al. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease： results from the CREDENCE trial and meta-analysis［J］. Stroke，2021，52（5）： 1545-1556.
|
| [57] |
Byrne NJ，Matsumura N，Maayah ZH，et al. Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 （nucleotide-binding domain-like receptor protein 3） inflammasome activation in heart failure［J］. Circ Heart Fail，2020，13（1）： e006277.
|
| [58] |
White JP，Cibelli M，Urban L，et al. TRPV4： molecular conductor of a diverse orchestra［J］. Physiol Rev，2016，96（3）： 911-973.
|
| [59] |
Wang Z，Zhou L，An D，et al. TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice［J］. Cell Death Dis，2019，10（6）： 386.
|
| [60] |
Elrashidy RA，Hasan RA. Modulation of autophagy and transient receptor potential vanilloid 4 channels by montelukast in a rat model of hemorrhagic cystitis［J］. Life Sci，2021，278： 119507.
|
| [61] |
Vincent F，Duncton MA. TRPV4 agonists and antagonists［J］. Curr Top Med Chem，2011，11（17）： 2216-2226.
|
| [62] |
Lawhorn BG，Brnardic EJ，Behm DJ. TRPV4 antagonists：a patent review （2015-2020）［J］. Expert Opin Ther Pat，2021，31（9）： 773-784.
|
| [63] |
Goyal N，Skrdla P，Schroyer R，et al. Clinical pharmacokinetics，safety，and tolerability of a novel，first-in-class TRPV4 ion channel inhibitor，GSK2798745，in healthy and heart failure subjects［J］. Am J Cardiovasc Drugs，2019，19（3）： 335-342.
|
百度学术
下载:
